Common reasons for temporary discontinuation include: Gastrointestinal adverse effects Nausea, vomiting, diarrhea, and constipation are the most frequently reported side effects, particularly during dose escalation
Current evidence, including magnetic resonance imaging studies, suggests that skeletal muscle alterations resulting from GLP-1 RA-induced weight loss, such as enhanced insulin sensitivity and reduced muscle fat infiltration, are adaptive, thereby improving muscle quality despite concurrent reductions in lean mass [112]
Autoimmunity is caused by the actions of a few specific cells in the immune system, meaning that broad-based anti-inflammatory/immunosuppressant drugs that are capable of reducing autoimmune effects, will inevitably do this at the expense of a normal functional immune system
Thus, you feel less hungry and eat less, resulting in weight loss
In the AWARD-11 trial, the efficacy and safety of 3.0 mg and 4.5 mg dulaglutide was evaluated at 36 and 52 weeks
El-Gohary Y, Tulachan S, Wiersch J, Guo P, Welsh C, Prasadan K,